vs

Side-by-side financial comparison of GRID DYNAMICS HOLDINGS, INC. (GDYN) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

GRID DYNAMICS HOLDINGS, INC. is the larger business by last-quarter revenue ($106.2M vs $69.8M, roughly 1.5× RIGEL PHARMACEUTICALS INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 0.3%, a 383.7% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs 5.9%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 15.3%).

Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

GDYN vs RIGL — Head-to-Head

Bigger by revenue
GDYN
GDYN
1.5× larger
GDYN
$106.2M
$69.8M
RIGL
Growing faster (revenue YoY)
RIGL
RIGL
+15.3% gap
RIGL
21.2%
5.9%
GDYN
Higher net margin
RIGL
RIGL
383.7% more per $
RIGL
384.0%
0.3%
GDYN
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
15.3%
GDYN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GDYN
GDYN
RIGL
RIGL
Revenue
$106.2M
$69.8M
Net Profit
$306.0K
$268.1M
Gross Margin
34.0%
91.5%
Operating Margin
0.5%
33.2%
Net Margin
0.3%
384.0%
Revenue YoY
5.9%
21.2%
Net Profit YoY
-93.2%
1769.2%
EPS (diluted)
$0.01
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GDYN
GDYN
RIGL
RIGL
Q4 25
$106.2M
$69.8M
Q3 25
$104.2M
$69.5M
Q2 25
$101.1M
$101.7M
Q1 25
$100.4M
$53.3M
Q4 24
$100.3M
$57.6M
Q3 24
$87.4M
$55.3M
Q2 24
$83.0M
$36.8M
Q1 24
$79.8M
$29.5M
Net Profit
GDYN
GDYN
RIGL
RIGL
Q4 25
$306.0K
$268.1M
Q3 25
$1.2M
$27.9M
Q2 25
$5.3M
$59.6M
Q1 25
$2.9M
$11.4M
Q4 24
$4.5M
$14.3M
Q3 24
$4.3M
$12.4M
Q2 24
$-817.0K
$-1.0M
Q1 24
$-3.9M
$-8.2M
Gross Margin
GDYN
GDYN
RIGL
RIGL
Q4 25
34.0%
91.5%
Q3 25
33.3%
93.2%
Q2 25
34.1%
95.6%
Q1 25
36.8%
91.7%
Q4 24
36.9%
89.9%
Q3 24
37.4%
85.5%
Q2 24
35.6%
92.4%
Q1 24
34.7%
93.1%
Operating Margin
GDYN
GDYN
RIGL
RIGL
Q4 25
0.5%
33.2%
Q3 25
-0.2%
40.9%
Q2 25
-0.1%
60.1%
Q1 25
-2.0%
23.9%
Q4 24
1.3%
28.9%
Q3 24
2.4%
25.4%
Q2 24
0.0%
1.2%
Q1 24
-6.9%
-23.6%
Net Margin
GDYN
GDYN
RIGL
RIGL
Q4 25
0.3%
384.0%
Q3 25
1.1%
40.2%
Q2 25
5.2%
58.6%
Q1 25
2.9%
21.5%
Q4 24
4.5%
24.9%
Q3 24
4.9%
22.5%
Q2 24
-1.0%
-2.8%
Q1 24
-4.9%
-27.9%
EPS (diluted)
GDYN
GDYN
RIGL
RIGL
Q4 25
$0.01
$14.11
Q3 25
$0.01
$1.46
Q2 25
$0.06
$3.28
Q1 25
$0.03
$0.63
Q4 24
$0.06
$0.82
Q3 24
$0.05
$0.70
Q2 24
$-0.01
$-0.06
Q1 24
$-0.05
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GDYN
GDYN
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$342.1M
$155.0M
Total DebtLower is stronger
$52.5M
Stockholders' EquityBook value
$542.1M
$391.5M
Total Assets
$612.9M
$513.6M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GDYN
GDYN
RIGL
RIGL
Q4 25
$342.1M
$155.0M
Q3 25
$338.6M
$137.1M
Q2 25
$336.8M
$108.4M
Q1 25
$325.5M
$77.1M
Q4 24
$334.7M
$77.3M
Q3 24
$231.3M
$61.1M
Q2 24
$256.0M
$49.1M
Q1 24
$249.4M
$49.5M
Total Debt
GDYN
GDYN
RIGL
RIGL
Q4 25
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
GDYN
GDYN
RIGL
RIGL
Q4 25
$542.1M
$391.5M
Q3 25
$537.7M
$117.6M
Q2 25
$532.2M
$81.9M
Q1 25
$517.4M
$18.6M
Q4 24
$517.8M
$3.3M
Q3 24
$400.2M
$-14.6M
Q2 24
$388.4M
$-29.9M
Q1 24
$382.8M
$-31.7M
Total Assets
GDYN
GDYN
RIGL
RIGL
Q4 25
$612.9M
$513.6M
Q3 25
$613.2M
$242.5M
Q2 25
$608.9M
$206.7M
Q1 25
$590.9M
$176.0M
Q4 24
$592.2M
$164.0M
Q3 24
$477.3M
$139.4M
Q2 24
$443.6M
$128.4M
Q1 24
$435.3M
$126.5M
Debt / Equity
GDYN
GDYN
RIGL
RIGL
Q4 25
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GDYN
GDYN
RIGL
RIGL
Operating Cash FlowLast quarter
$9.9M
$22.0M
Free Cash FlowOCF − Capex
$6.1M
FCF MarginFCF / Revenue
5.7%
Capex IntensityCapex / Revenue
3.6%
Cash ConversionOCF / Net Profit
32.34×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$25.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GDYN
GDYN
RIGL
RIGL
Q4 25
$9.9M
$22.0M
Q3 25
$7.0M
$24.0M
Q2 25
$14.4M
$30.5M
Q1 25
$9.4M
$-893.0K
Q4 24
$7.1M
$14.5M
Q3 24
$9.2M
$21.7M
Q2 24
$10.7M
$302.0K
Q1 24
$3.2M
$-5.0M
Free Cash Flow
GDYN
GDYN
RIGL
RIGL
Q4 25
$6.1M
Q3 25
$2.9M
Q2 25
$10.2M
Q1 25
$6.0M
Q4 24
$4.4M
Q3 24
$5.9M
Q2 24
$8.0M
Q1 24
$43.0K
FCF Margin
GDYN
GDYN
RIGL
RIGL
Q4 25
5.7%
Q3 25
2.8%
Q2 25
10.1%
Q1 25
6.0%
Q4 24
4.4%
Q3 24
6.8%
Q2 24
9.7%
Q1 24
0.1%
Capex Intensity
GDYN
GDYN
RIGL
RIGL
Q4 25
3.6%
Q3 25
3.9%
Q2 25
4.1%
Q1 25
3.3%
Q4 24
2.6%
Q3 24
3.7%
Q2 24
3.2%
Q1 24
4.0%
Cash Conversion
GDYN
GDYN
RIGL
RIGL
Q4 25
32.34×
0.08×
Q3 25
5.92×
0.86×
Q2 25
2.73×
0.51×
Q1 25
3.21×
-0.08×
Q4 24
1.56×
1.01×
Q3 24
2.15×
1.75×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GDYN
GDYN

Other$30.6M29%
Technology Media And Telecom$30.1M28%
Financial Service$24.3M23%
Manufactured Product Other$10.8M10%
Related Party$7.6M7%
Health Care$2.8M3%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons